Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achilles Therapeutics plc

1.48
+0.0000
Volume:- -
Turnover:- -
Market Cap:60.83M
PE:-0.89
High:1.48
Open:1.48
Low:1.48
Close:1.48
Loading ...

Achilles Therapeutics Announces Voluntary Liquidation and Delisting

TIPRANKS
·
21 Mar

Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration

GlobeNewswire
·
28 Feb

February 2025's Promising Penny Stocks On US Exchanges

Simply Wall St.
·
05 Feb

Achilles Therapeutics Announces Board Resignations Amid Strategic Realignment

TIPRANKS
·
07 Jan

Achilles Therapeutics Sells Key Assets to AstraZeneca

TIPRANKS
·
27 Dec 2024

Achilles Therapeutics Sells Technology Assets to AstraZeneca for $12 Million, Concluding Strategic Review; Shares Up

MT Newswires Live
·
24 Dec 2024

Achilles Therapeutics sells technology assets to AstraZeneca for $12M

TIPRANKS
·
24 Dec 2024

Press Release: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

Dow Jones
·
24 Dec 2024

Achilles Therapeutics Reports Q3 2024 Financial Results

TIPRANKS
·
29 Nov 2024

Achilles Therapeutics receives approval to transfer to Nasdaq Capital Market

TIPRANKS
·
19 Nov 2024

BRIEF-Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market

Reuters
·
19 Nov 2024

Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market

GlobeNewswire
·
19 Nov 2024

Achilles Therapeutics Explores Strategic Options Amid Financial Update

TIPRANKS
·
14 Nov 2024

Achilles Therapeutics PLC reports results for the quarter - Earnings Summary

Reuters
·
14 Nov 2024

Achilles Therapeutics Q3 2024 GAAP EPS $(0.48), Inline, Cash Position Of $86.1M

Benzinga
·
14 Nov 2024

Achilles Therapeutics PLC expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
08 Nov 2024

European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading

MT Newswires Live
·
23 Sep 2024

Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?

Zacks
·
23 Sep 2024